Michael Cookson, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Merck
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astellas Pharma, Inc.
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    MDxHealth
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Janssen Scientific Affairs, LLC
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer Healthcare Pharmaceuticals
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Precision Biopsy
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Ferring Pharmaceuticals
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Janssen Biotech, Inc.
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer Healthcare Pharmaceuticals
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    MDx Health
    Date added:
    Date updated:
    11/05/2024

Pages

Return to Evolving Role of the Urologist in Metastatic and Castration Resistant Prostate Cancer: A Guidelines and Case-Based Discussion - Washington, D.C. (2019)